Application Note | August 12, 2014

Systematic Method Development Of UPC2 Conditions Using Opioid Drugs

Source: Waters Corporation

By Jonathan P. Danaceau, Kenneth J. Fountain, and Erin E. Chambers, Waters Corporation

This application note uses a panel of natural and synthetic opioid drugs to demonstrate the use of a systematic screening strategy for UPC2 method development. The simultaneous evaluation of multiple column chemistries and several different mobile-phase additives allows rapid determination of preferred starting conditions for further optimization. This enabled easy and rapid optimization of conditions to achieve a method capable of analyzing 19 different opioid drugs in less than 2 minutes, with acceptable retention and peak shape for all compounds. In addition, this method further highlights the potential utility of UPC2 for the analysis of a wide variety of compound classes.


For full access to this content, please Register or Sign In.

Access Content Systematic Method Development Of UPC2 Conditions Using Opioid Drugs
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.